Gene News and Research

Latest Gene News and Research

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Myc genes play key role in self-renewal of spermatogonial stem cells

Myc genes play key role in self-renewal of spermatogonial stem cells

Research reveals how microbial context during infectious disease can compromise antibiotic therapy

Research reveals how microbial context during infectious disease can compromise antibiotic therapy

Mutations linked to endometrial cancer can be detected in uterine lavage fluid, study reveals

Mutations linked to endometrial cancer can be detected in uterine lavage fluid, study reveals

New database of PCR primers enables effective detection and identification of RNA viruses

New database of PCR primers enables effective detection and identification of RNA viruses

Researchers explore how neuronal activity influences CREB dynamics

Researchers explore how neuronal activity influences CREB dynamics

Novel murine model helps shed light on mechanisms involved in reversible infantile liver failure

Novel murine model helps shed light on mechanisms involved in reversible infantile liver failure

Potential drug could become first effective treatment option for Prader-Willi syndrome

Potential drug could become first effective treatment option for Prader-Willi syndrome

Whitehead Institute researchers identify mechanism underlying cancer drug-resistance

Whitehead Institute researchers identify mechanism underlying cancer drug-resistance

C elegans could be powerful model for understanding how nervous systems produce behaviors

C elegans could be powerful model for understanding how nervous systems produce behaviors

New findings about key cellular protein could lead to treatments for neurodegenerative diseases

New findings about key cellular protein could lead to treatments for neurodegenerative diseases

New discovery could lead to effective drugs to prevent excessive lymphatic growth in cancer

New discovery could lead to effective drugs to prevent excessive lymphatic growth in cancer

CSHL researcher-inventor hails FDA approval of new SMA drug

CSHL researcher-inventor hails FDA approval of new SMA drug

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

Johns Hopkins scientists find link between sleep/wake cycles and core body temperature

Johns Hopkins scientists find link between sleep/wake cycles and core body temperature

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Genomic sequencing reveals new insights into major shigellosis outbreaks in California

Genomic sequencing reveals new insights into major shigellosis outbreaks in California

Caltech scientists develop simple way to visualize gene expression with MRI

Caltech scientists develop simple way to visualize gene expression with MRI

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.